ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Ex Vivo Allograft Perfusion for Complex Pediatric Heart Transplant Recipients

Friday, October 29, 2021

Submitted by

Christopher Anderson

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2020.12.025

Author(s)

Thilo P.K. Fleck, MD, Rafael Ayala, MD, Johannes Kroll, MD, Matthias Siepe, MD, David Schibilsky, MD, Christoph Benk, PhD, Sven Maier, MSc, Katja Reineker, MD, René Hoehn, MD, Frank Humburger, MD, Friedhelm Beyersdorf, MD, Brigitte Stiller, MD

Pediatric heart transplant (HTx) recipients with congenital heart defects need complex concomitant surgical procedures with the risk of prolonging the allograft’s ischemic time. Ex vivo allograft perfusion with the Organ Care System (OCS; Transmedics, Andover, MA) may improve survival of these challenging patients.